Ads
related to: brain tumor, study- Precision Oncology
Finding Cancer's Fingerprint.
Learn More.
- Contact Us
Have Questions? Don’t Hesitate.
Contact Us Today.
- NRG1 Fusion
More Aggressive Than You Think.
Learn About NGR1 Today.
- Genomic Landscape
Genomics are Changing the Future
of Oncology. Learn More.
- Precision Oncology
Search results
New research platform assesses brain cancer mutations during surgery
Medical Xpress· 4 days agoBrain cancer is difficult to treat when it starts growing, and a prevalent type, known as a glioma, has a poor five-year survival rate. In a new study published ...
Trial of hormonal gel shows promise for male birth control
UPI· 4 hours agoA new hormonal gel could one day be a potential form of birth control for men, researchers reported...
Innovent Announces Data from Pivotal Phase 2 TRUST-I Study of Taletrectinib(ROS1 Inhibitor) are...
Lake Arrowhead Mountain News· 2 days ago...01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncology, cardiovascular and metabolic, autoimmune, ophthalmology and other major diseases, announced that results from the pivotal Phase 2 TRUST-I study...
Musk's Neuralink seeks to enroll three patients in brain implant study
KSL Salt Lake City· 7 days agoElon Musk's brain-chip startup, Neuralink, seeks to enroll three patients to evaluate its device in...
...Nuvation Bio Announces Data from Pivotal Phase 2 TRUST-I Study of its Investigational ROS1...
Morningstar· 2 days agoNuvation Bio Announces Data from Pivotal Phase 2 TRUST-I Study of its Investigational ROS1 Inhibitor, Taletrectinib, are Published in the Journal of Clinical Oncology and ...
New Lung Cancer Drug Trial Hailed As Best Result Ever, Setting A “New Benchmark”
IFLScience· 10 hours agoPhase III trial results for a new drug targeting advanced lung cancer have just been reported, with...
Updated Data from the Phase 1/2 Study of Olomorasib in KRAS G12C-Mutant Advanced Solid Tumors...
KOLR - KSFX Ozarks· 3 days agoEli Lilly and Company (NYSE: LLY) today announced updated data from the Phase 1/2 clinical trial evaluating olomorasib as a monotherapy in patients with KRAS G12C-mutant advanced solid tumors ...
New research platform assesses brain cancer mutati | Newswise
Newswise· 5 days agoJACKSONVILLE, Fla. — Brain cancer is difficult to treat when it starts growing, and a prevalent type, known as a glioma, has a poor five-year survival rate. In a new
Mom of Soon-to-be-Saint Carlo Acutis: Son Offers ‘a Spirituality That Can Be Followed by Everybody’
National Catholic Register· 5 hours agoCarlo Acutis will soon be a saint. Antonia Salzano Acutis, the mother of Blessed Carlo Acutis, spoke...
Medicenna Reports Significant Survival Benefit in Patients with Recurrent Glioblastoma Following...
Digital Journal· 12 hours agoFahar Merchant, President and CEO...
Ad
related to: brain tumor, study